Health Sciences 4620F/G Chapter Notes - Chapter 1: Chlorpromazine, Hydrotherapy, Induced Coma
Document Summary
151-152: lucentis is a drug that was approved by health canada in 2007. Used to treat wet macular denervation and is very effective. It costs 2000$ per person so very expensive: avastin is a drug that was approved to treat colon cancer. But it is effective at treating wmd as well. Question is: should the province subsidize lucentis, should the province approve use of avastin for. Wmd: what political dynamics underlie the administrative issues determining which drug should be covered under provincial health insurance, wealthier provinces are more likely to cover lucentis. Smaller provinces have faced a lot of political pressure. This debate launched a study in the us in 2008: next to hospital costs, spending on drugs is the largest category of healthcare expenditure in canada. Total spending reached 30 billion dollars in 2009. 156-157: the argument for a nationalized health care plan mirrors the justification for a national medicare program in terms of equity.